Press-release for stocks related to drug

Prices are updated after-hours

Eyenovia Announces FDA Acceptance of New Drug Application for MydCombi™ for In-Office Pupil Dilation
Published: 2022-12-13 (Crawled : 15:00) - eyenoviabio.com
EYEN | $0.5835 7.54% 7.99% 770K

| -66.47% | O: 5.2% H: 5.49% C: 2.2%
fda drug application

Eyenovia Announces Reclassification of MydCombi™ as Drug-Device Combination Product by FDA
Published: 2021-10-25 (Crawled : 13:00) - eyenoviabio.com
EYEN | $0.5835 7.54% 7.99% 770K

| -90.37% | O: -31.64% H: 5.71% C: -2.31%
fda eye drug device mydcombi

61%

39%

CSSE 4 | $0.4253 179.25% 64.77% 210M

BOF | $2.08 77.78% 41.21% 110M

ILAG | $0.54 12.27% 40.62% 3.7M

LICN | $0.999 78.39% 40.49% 15M

AMST | $3.4 70.0% 39.58% 70M

MTC | $3.6 60.71% 38.04% 9.1M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.458 14.5% 30.92% 91K

MULN | News | $3.77 38.1% 27.78% 13M

RILY | $29.75 36.97% 27.26% 12M

Save your searches and get alerts when important news are released.